Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-16T17:53:08.316Z Has data issue: false hasContentIssue false

ExacTech Blood Glucose Meter Clinical Trial

Published online by Cambridge University Press:  28 June 2012

Edward A. Bartkus*
Affiliation:
Department of Emergency Medicine, Oregon Health Sciences University, Portland, Oregon
Mohamud Daya
Affiliation:
Department of Emergency Medicine, Oregon Health Sciences University, Portland, Oregon
Jerris R. Hedges
Affiliation:
Department of Emergency Medicine, Oregon Health Sciences University, Portland, Oregon
Jonathan Jui
Affiliation:
Department of Emergency Medicine, Oregon Health Sciences University, Portland, Oregon
*
Department of Emergency Medicine, UHN-52, Oregon Health, Sciences University, 3181 SW Sam Jackson Park Road, Portland, OR 97201-3098 USA

Abstract

Introduction:

Current prehospital protocols for the management of patients with altered mental status include the empiric administration of hypertonic glucose, naloxone, and thiamine. The injudicious use of 50% dextrose (D50W) may result in hyperosmolarity, a worsening of hypokalemia, and unwarranted additional health-care costs for the patient. The administration of D50W also may worsen the neurological outcome of patients with local or generalized ischemia.

Objective:

To evaluate the ExacTech blood glucose meter's ability to estimate blood glucose levels accurately and rapidly.

Methods:

Emergency medical technicians (EMTs) from selected advanced life support (ALS) units in the Portland, Ore., metropolitan area participated in a prospective clinical trial of the ExacTech blood glucose meter. A convenience sample, was drawn from emergency medical services (EMS) patients with suspected diabetic emergencies, altered mental status, and other neurological deficits. Venous blood samples were drawn from these populations at the same time as the ExacTech readings were obtained. The venous blood was submitted to the receiving hospitals for laboratory analysis of blood glucose levels, and a comparison was made between the results of the two methods.

Results:

A total of 80 matched sets of data were obtained from 1 April 1990 through 6 May 1991. The hospital blood glucose values ranged from 8 to 1233 mg/dl. Sixteen (20%) of the patients were hypoglycemic (<60 mg/dl) and 23 (28.8%) were hyperglycemic (>180 mg/dl). The ExacTech device sensitivity and specificity for hypoglycemia using venous samples were 94.6% and 89.2%, respectively. For hyperglycemia, these same parameters were 87.5% and 97.1%. Pearson's r over the range of the instrument (40–450 mg/dl) was 0.8656 (p <.001). If the prehospital “definition” of hypoglycemia (for threshold-to-treat) is raised to 65 mg/dl, the device has 100% sensitivity in the sample population.

Conclusion:

The device functioned accurately and consistently in the prehospital environment over a wide range of temperatures, and in the hands of many different individuals.

Information

Type
Original Research
Copyright
Copyright © World Association for Disaster and Emergency Medicine 1993

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable